Annovis Share Price
NYSE: ANVS | Micro Cap | HealthcareAnnovis Stock Performance
Annovis Share Price Today
As of 19 November 2026, Annovis Bio, Inc.'s share price is $0.82. The stock opened at $0.76, compared to its previous close of $0.74. During today's trading session, Annovis Bio, Inc.'s share price traded between $0.74 and $0.82, with an average price of $0.78. Over the past 52 weeks, the stock has recorded a high of $5.50 and a low of $0.62. In terms of performance, Annovis Bio, Inc.'s share price has declined by 57.50% over the last six months and is down 84.00% on a year-on-year basis.
Annovis Share Price Chart
Annovis Quarterly Profit & Loss
All figures in USD
Annovis Annual Profit & Loss
All figures in USD
Annovis Balance Sheet
All figures in USD Million
Annovis Cash Flow
About Annovis
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
Annovis Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.17 | $0.82 | -27.79% |
Oct 2026 | $1.26 | $1.13 | -11.72% |
Sep 2026 | $1.69 | $1.28 | -28.89% |
Aug 2026 | $1.75 | $1.80 | +2.86% |
Jul 2026 | $1.89 | $1.75 | -5.66% |
Jun 2026 | $1.96 | $1.85 | -3.39% |
May 2026 | $1.98 | $1.92 | -2.54% |
Apr 2026 | $2.26 | $1.97 | -11.26% |
Mar 2026 | $2.56 | $2.22 | -17.16% |
Feb 2026 | $2.70 | $2.68 | +0.00% |
Jan 2026 | $3.40 | $2.68 | -21.64% |
Dec 2025 | $5.09 | $3.42 | -32.94% |
